Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV002052217 | SCV002318790 | uncertain significance | Recessive dystrophic epidermolysis bullosa | 2022-03-22 | criteria provided, single submitter | clinical testing | he variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. It is not observed in the gnomAD v2.1.1 dataset. TIn silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.921>=0.6, 3CNET: 0.937>=0.75). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |